Published in Nat Protoc on April 25, 2013
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
Quality control method for RNA-seq using single nucleotide polymorphism allele frequency. Genes Cells (2014) 1.06
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med (2015) 0.92
Teratoma formation: a tool for monitoring pluripotency in stem cell research. Curr Protoc Stem Cell Biol (2015) 0.85
Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells. Stem Cell Reports (2016) 0.81
The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis. Nat Commun (2016) 0.79
Landscape of genomic alterations in pituitary adenomas. Clin Cancer Res (2016) 0.75
CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data. Bioinformatics (2014) 0.75
The transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features. Sci Rep (2016) 0.75
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq. Nat Commun (2016) 0.75
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells. PLoS Genet (2017) 0.75
Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet (2017) 0.75
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol (2007) 4.53
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol (2008) 2.79
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet (2005) 2.68
CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics (2004) 2.65
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol (2011) 1.98
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell (2011) 1.54
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Protocols for cytogenetic studies of human embryonic stem cells. Methods (2008) 1.30
Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res (2010) 1.27
Inducing iPSCs to escape the dish. Cell Stem Cell (2011) 1.03
Genomic stability in reprogramming. Curr Opin Genet Dev (2012) 1.02
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (2012) 1.01
Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (2010) 0.95
Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nat Struct Mol Biol (2011) 0.95
Human embryonic stem cells and genomic instability. Regen Med (2009) 0.90
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol (2009) 3.96
Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell (2011) 3.73
The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer (2011) 3.42
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
Ethics. The ISSCR guidelines for human embryonic stem cell research. Science (2007) 2.62
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
The tumorigenicity of human embryonic stem cells. Adv Cancer Res (2008) 2.32
Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (2006) 2.27
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (2004) 2.07
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell (2013) 2.02
Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells (2009) 1.98
Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (2003) 1.75
Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim (2010) 1.70
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 1.53
Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod (2004) 1.49
Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res (2004) 1.39
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol (2009) 1.39
Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (2008) 1.38
Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells (2009) 1.30
Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res (2010) 1.27
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol (2004) 1.25
The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (2009) 1.17
Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells (2010) 1.15
Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat Commun (2013) 1.12
Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells (2008) 1.11
Expanding the boundaries of embryonic stem cells. Cell Stem Cell (2012) 1.06
The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nat Biotechnol (2005) 1.06
Human embryonic stem cells as a cellular model for human disorders. Mol Cell Endocrinol (2006) 1.05
Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Rev (2011) 1.02
Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One (2009) 1.02
Genomic stability in reprogramming. Curr Opin Genet Dev (2012) 1.02
A molecular view on pluripotent stem cells. FEBS Lett (2002) 1.02
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (2012) 1.01
Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem (2005) 1.01
Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells (2007) 1.00
Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Dev Dyn (2002) 0.99
Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells (2006) 0.98
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. J Mol Cell Biol (2012) 0.96
Human embryonic stem cells as a model for early human development. Best Pract Res Clin Obstet Gynaecol (2004) 0.95
Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (2010) 0.95
Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nat Struct Mol Biol (2011) 0.95
Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports (2013) 0.94
The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells (2006) 0.94
Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell (2010) 0.92
Human embryonic stem cells: the battle between self-renewal and differentiation. Regen Med (2006) 0.88
Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells (2011) 0.87
Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies. Stem Cells (2010) 0.86
Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cell Dev Biol Anim (2010) 0.86
Factors controlling human embryonic stem cell differentiation. Methods Enzymol (2003) 0.85
Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J Cell Mol Med (2010) 0.83
Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts. Stem Cell Rev (2009) 0.83
A computerized database-scan to identify c-MYC targets. Gene (2002) 0.82
Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells (2012) 0.81
Involvement of parental imprinting in the antisense regulation of onco-miR-372-373. Nat Commun (2013) 0.81
Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markers. Stem Cell Rev (2012) 0.80
The "brainy side" of human embryonic stem cells. J Neurosci Res (2004) 0.80
New balance in pluripotency: reprogramming with lineage specifiers. Cell (2013) 0.80
The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Res (2012) 0.79
Human pluripotent stem cells with distinct X inactivation status show molecular and cellular differences controlled by the X-Linked ELK-1 gene. Cell Rep (2013) 0.79
Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regen Med (2011) 0.78
Manipulation of the human genome in human embryonic stem cells. Stem Cell Rev (2005) 0.77
New ISSCR guidelines: clinical translation of stem cell research. Lancet (2016) 0.77
Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends Cardiovasc Med (2003) 0.76
DUXO, a novel double homeobox transcription factor, is a regulator of the gastrula organizer in human embryonic stem cells. Stem Cell Res (2012) 0.76
Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization. Stem Cell Res (2011) 0.76
Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. Stem Cells (2015) 0.76
Corrigendum: Hallmarks of pluripotency. Nature (2015) 0.75
Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome. Int J Dev Biol (2017) 0.75
Human ES cell lines--introduction. In Vitro Cell Dev Biol Anim (2010) 0.75